Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Property, Plant & Equipment
The pp&e for Labcorp Holdings Inc. (LH) is $3.08 Billion with a year-over-year change of +1.19%. Property, Plant & Equipment (PP&E) represents the long-term tangible assets used in operations, including land, buildings, machinery, and equipment, shown net of accumulated depreciation.
LH PP&E Chart
LH PP&E
$3.08B+707.73% 20Y
Zoom
Current PP&E
$3.08B
$3.08 Billion
Year-over-Year Change
+1.19%
vs. $3.05B prior year
Historical Data
30
Years of data available
Annual PP&E History
| Year | PP&E | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.08B | +$36.10M | +1.19% |
| 2024 | $3.05B | +$133.60M | +4.59% |
| 2023 | $2.91B | +$117.70M | +4.21% |
| 2022 | $2.79B | $-21.30M | -0.76% |
| 2021 | $2.82B | +$85.80M | +3.14% |
| 2020 | $2.73B | +$118.00M | +4.52% |
| 2019 | $2.61B | +$826.90M | +46.33% |
| 2018 | $1.78B | +$35.80M | +2.05% |
| 2017 | $1.75B | +$30.30M | +1.76% |
| 2016 | $1.72B | $-28.80M | -1.65% |
| 2015 | $1.75B | +$960.90M | +122.17% |
| 2014 | $786.50M | +$79.10M | +11.18% |
| 2013 | $707.40M | +$76.60M | +12.14% |
| 2012 | $630.80M | +$52.50M | +9.08% |
| 2011 | $578.30M | $-8.60M | -1.47% |
| 2010 | $586.90M | +$86.10M | +17.19% |
| 2009 | $500.80M | +$4.40M | +0.89% |
| 2008 | $496.40M | +$57.20M | +13.02% |
| 2007 | $439.20M | +$46.00M | +11.70% |
| 2006 | $393.20M | +$11.70M | +3.07% |
| 2005 | $381.50M | +$21.50M | +5.97% |
| 2004 | $360.00M | $-1.30M | -0.36% |
| 2003 | $361.30M | +$10.10M | +2.88% |
| 2002 | $351.20M | +$41.90M | +13.55% |
| 2001 | $309.30M | +$36.50M | +13.38% |
| 2000 | $272.80M | $-400,000 | -0.15% |
| 1999 | $273.20M | +$14.10M | +5.44% |
| 1998 | $259.10M | +$4.20M | +1.65% |
| 1997 | $254.90M | $-28.00M | -9.90% |
| 1996 | $282.90M | — | — |
Related Metrics
Data as of Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter